Background Image
Table of Contents Table of Contents
Previous Page  144 / 64 Next Page
Basic version Information
Show Menu
Previous Page 144 / 64 Next Page
Page Background

144

Antonio Jiménez-Pacheco

Análisis de una serie de 32 tumores del tracto urinario superior

CONCLUSION

Los tumores del tracto urinario superior son una entidad

poco frecuente, donde la urografía por tomografía computeriza-

da multidetector (UTCMD) se ha convertido en el gold estandar

de las exploraciones radiológicas en el diagnóstico y seguimiento

de este tipo de tumores.

El gold estandar del tratamiento de los tumores del TUS, in-

dependientemente de la localización del tumor, continúa siendo

la nefroureterectomía radical con rodete vesical, aunque la ciru-

gía conservadora de nefronas en sus diferentes técnicas, es en la

actualidad una buena alternativa en casos seleccionados.

A pesar de ser una casuística limitada, los resultados obteni-

dos son satisfactorios independientemente de la técnica quirúrgi-

ca empleada al ser la supervivencia libre de enfermedad en el pe-

riodo de seguimiento del 100% y la mortalidad cáncer-específica

del 0%.

REFERENCIAS

1.

Suriano F, Brancato T. Nephron-sparing management of upper

tract urothelial carcinoma. Rev Urol 2014; 16:21-28.

2.

Rouprêta M, Zigeunerb R, Palou A, et al. European guidelines

for the diagnosis and management of upper urinary tract

urothelial cell carcinoma 2011 update. Eur Urol 2011; 59:

584-94.

3.

Liatsikos EN, Dinlenc CZ, Kapoor R, Smith AD. Transitional-cell

carcinoma of the renal pelvis: ureteroscopic and percutaneous

approach. J Endourol 2001; 15:377-83.

4.

Rouprêt M, Babjuk M, Compérat E, et al. European guidelines

on upper tract urothelial carcinomas: 2013 update. Eur Urol

2013; 63:1059-71.

5.

Sverrisson EF, Kim T, Espiritu PN, et al. The merits of cytology

in the work up for upper tract urothelial carcinoma - a

contemporary review of a perplexing issue. Int Braz J Urol

2014; 40: 493-8.

6.

Visser O, Adolfsson J, Rossi S, et al. Incidence and survival of

rare urogenital cancers in Europe. Eur J Cancer 2012; 48:456-

64.

7.

Yakoubi R, Colin P, Seisen T, et al. Radical nephroureterectomy

versus endoscopic procedures for the treatment of localised

upper tract urothelial carcinoma: A meta-analysis and a

systematic review of current evidence from comparative

studies. Eur J Surg Oncol 2014; 40: 1629-34.

8.

Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial

carcinoma: Current treatment and outcomes. Urology 2012;

79: 749-56.

9.

Martín Martín S, Calleja Escudero J, Trueba Arguiñarena FJ,

Rivero Martínez MD, Sanz Ruiz A, Fernández del Busto E.

Tumores del tracto urinario superior. Nuestra experiencia.

Arch Esp Urol 2008; 61: 499-506.

10. Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF.

Effect of smoking on outcomes of urothelial carcinoma: A

systematic review of the literature. Eur Urol 2014; 65: 742-54.

11. Fanigan R. Tumores uroteliales de las vías urinarias. En Wein

AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-

Walsh Urology. 9th ed. Buenos Aires: Editorial Médica

Panamericana; 2008. p: 1638-52.

12. Wan LJ, Wong YC, Huang CC, Wu CH, Hung SC, Chen HW.

Multidetector computerized tomography urography is more

accurate tan excretory urography for diagnosing transitional

cell carcinoma of the upper urinary tract in adults with

hematuria. J Urol 2010; 183: 48-55.

13. Cowan NC. CT urography for hematuria. Nature 2012; 9: 218-

26.

14. Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST. Diagnostic

accuracy of transitional cell carcinoma on multidetector

computerized tomography urography in patients with gross

hematuria. J Urol 2009; 181: 524-31.

15. Takahashi N, Glockner JF, Hartman RP, et al. Gadolinium

enhanced magnetic resonance urography for upper urinary

tract malignacy. J Urol 2010; 183: 1330-65.

16. Izquierdo Reyes L. Tumores del tracto urinario superior. Clin

Urolog 2012; 4: 7-16.

17. Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a por

performance for predicting invasive or high-grade upper-tract

urothelial carcinoma. BJU Int 2011; 108(5): 701-5.

18. Mian C, Mazzoleni G, Vikoler S, et al. Fluorescence in situ

hybridisation in the diagnosis of upper urinary tract tumours.

Eur Urol 2010; 58: 288-92.

19. Jovanovic M, Soldatovic I, Janjic A, et al. Diagnostic value of

the nuclear matrix protein 22 test and urine cytology in upper

tract urothelial tumors. Urol Int 2011; 87: 134-7.

20. Waldert M, Karakiewicz PI, Raman JD, et al. A delay in radical

nephroureterectomy can lead to upstaging. BJU Int 2010; 105:

812-7.

21. Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG,

Tolley DA. Ureteroscopic and percutaneous management of

upper tract urothelial carcinoma (UTUC): systematic review.

BJU Int 2012; 110:614-28.

22. Rouprêt M, Traxer O, Tligui M, et al. Upper urinary tract

transitional cell carcinoma: recurrence rate after percutaneous

endoscopic resection. Eur Urol 2007; 51:709-14.

23. Rouprêt M, Harmon JD, Sanderson KM, et al. Laparoscopic

distal ureterectomy and anastomosis for management of

low-risk upper urinary tract transitional cell carcinoma:

preliminary results. Br J Urol 2007; 99:623-27.

24. Goel MC, Matin SF, Derweesh I, Levin H, Streem S, Novick

AC. Partial nephrectomy for renal urothelial tumors: clinical

update. Urology 2006; 67:490-5.

25. Giannarini G, Schumacher MC, Thalmann GN, Bitton

A, Fleischmann A, Studer UE. Elective management of

transitional cell carcinoma of the distal ureter: can kidney-

sparing surgery be advised? BJU Int 2007; 100(2): 264-8.

26. Rastinehad AR, Ost MC, Vanderbrink BA, et al. A 20-year

experience with percutaneous resection of upper tract

transitional carcinoma: is there an oncologic benefit with

adjuvant bacillus Calmette Guérin therapy? Urology 2009; 73:

27-31.

27. Iborra I, Solsona E, Casanova J, Ricos JV, Rubio J, Climent

MA. Conservative elective treatment of upper urinary tract

tumors: a multivariate analysis of prognostic factors for

recurrence and progression. J Urol 2003; 169: 82-5.

28. Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term

experience with bacillus Calmette-Guerin therapy of upper

urinary tract transitional cell carcinoma in patients not eligible

for surgery. J Urol 2002; 168:1381-5.

29. Katz MH, Lee MW, Gupta M. Setting a new standards for